2000
DOI: 10.1159/000007322
|View full text |Cite
|
Sign up to set email alerts
|

Tunicamycin Treatment Reduces Intracellular Glutathione Levels: Effect on the Metastatic Potential of the Rhabdomyosarcoma Cell Line S4MH

Abstract: Highly metastatic cells are known to overexpress certain Asn-linked oligosaccharides in the plasmatic membrane. Another phenotypic characteristic of malignant cells consists in the expression of high levels of intracellular glutathione (GSH). The aim of the present work was to demonstrate that the inhibition of N-glycosylation induces changes in intracellular GSH levels, and in turn participates in the inhibition of the metastatic potential of tumor cells by tunicamycin treatment. Firstly, we demonstrated that… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
11
0

Year Published

2000
2000
2015
2015

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(12 citation statements)
references
References 49 publications
1
11
0
Order By: Relevance
“…Inhibition of N-glycan processing disrupts normal cell adhesion and reduces the tumourigenic and metastatic capacity in vivo of rhabdomyosarcoma cell line S4MH [32]. Deglycosylation of Hca-F cells by tunicamycin influences on cells adhesion in vitro [33].…”
Section: Discussionmentioning
confidence: 99%
“…Inhibition of N-glycan processing disrupts normal cell adhesion and reduces the tumourigenic and metastatic capacity in vivo of rhabdomyosarcoma cell line S4MH [32]. Deglycosylation of Hca-F cells by tunicamycin influences on cells adhesion in vitro [33].…”
Section: Discussionmentioning
confidence: 99%
“…Some reports revealed the correlation of GSH content with the metastatic activity of melanoma cells [27][28][29]. In the present study, we also reported a higher value of intracellular GSH in high potential metastatic B16F10 melanoma cells (45.22 nmol/10 6 cells) in comparison to low potential metastatic B16F1 melanoma cells (29.11 nmol/ 10 6 cells).…”
Section: Discussionsupporting
confidence: 85%
“…Notably, N-glycosylation participates in the adherence of circulating tumor cells to the microvascular bed essential for extravasation and facilitates metastasis from the blood or lymph to other organs (26). Consistently, treatment of the highly aggressive sarcoma cell line S4MH with the N-glycosylation inhibitor tunicamycin resulted in loss of tumor cell adherence to endothelial cells and a significant reduction in the metastatic capacity (27). Murine ADAM8 was shown to be N-glycosylated (28).…”
mentioning
confidence: 96%